interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development
EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
Clinical Trials Information System (CTIS).
The EU Clinical Trials Register currently displays
44338
clinical trials with a EudraCT protocol, of which
7368
are clinical trials conducted with subjects less than 18 years old.
The register also displays information on
18700
older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).
Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see
Frequently Asked Questions ).
3 result(s) found for: Reflex seizures.
Displaying page 1 of 1.
EudraCT Number: 2017-001180-20
Sponsor Protocol Number: E2007-G000-410
Start Date*: 2021-10-28
Sponsor Name:Eisai Inc.
Full Title: Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Genera...
Medical condition: Epilepsy:
Partial Onset Seizures with or without
1) Secondarily Generalized Seizures
2) Primary Generalized Tonic-Clonic Seizures
Disease:
Version
SOC Term
Classification Code
Term
Level
24.0
10029205 - Nervous system disorders
10085326
Parietal lobe epilepsy
PT
Population Age: Adolescents, Under 18, Adults, Elderly
Sponsor Name:National Cancer Institute Cancer Therapy Evaluation
Full Title: Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults with Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors
Medical condition: Ewing sarcoma, Rhabdomyosarcoma, Non rhabdomyosarcoma, Wilms Tumor, Osteosarcoma and Other Rare Tumors
Disease:
Population Age: Children, Adolescents, Under 18, Adults
Full Title: A multi-centre, randomised, double-blind, placebo-controlled Phase II study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of 2-iminobiotin (2-IB) in neonates with gestational...
Medical condition: Perinatal asphyxia
Disease:
Version
SOC Term
Classification Code
Term
Level
14.1
10038738 - Respiratory, thoracic and mediastinal disorders
10004943
Birth asphyxia
LLT
14.1
10038738 - Respiratory, thoracic and mediastinal disorders
10003500
Asphyxia neonatal
LLT
Population Age: Preterm newborn infants, Newborns, Under 18
Subscribe to this Search
To subscribe to the RSS feed for this search click
here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options:
Number of Trials to download:
Download Content:
Download Format:
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
• EEA CTAs: Date study was authorised to proceed • Outside EU/EEA: Date study was submitted in EudraCT